Related references
Note: Only part of the references are listed.Ghrelin increases intake of rewarding food in rodents
Emil Egecioglu et al.
ADDICTION BIOLOGY (2010)
Biochemical effects of SIRT1 activators
Joseph A. Baur
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
2,5-Disubstituted pyridines as potent GPR119 agonists
Yulin Wu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier
Jean-Marie Receveur et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Regulation of Energy Homeostasis by Bombesin Receptor Subtype-3: Selective Receptor Agonists for the Treatment of Obesity
Xiao-Ming Guan et al.
CELL METABOLISM (2010)
Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal Responses
Helen M. Cox et al.
CELL METABOLISM (2010)
Discovery of Adamantyl Ethanone Derivatives as Potent 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors
Xiangdong Su et al.
CHEMMEDCHEM (2010)
Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy
M. A. Valentino et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Nutrient sensing in the gastrointestinal tract
David H. Alpers
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality
Abel Romero-Corral et al.
EUROPEAN HEART JOURNAL (2010)
Sobetirome: a case history of bench-to-clinic drug discovery and development
Thomas S. Scanlan
HEART FAILURE REVIEWS (2010)
Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control
M-H Son et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice
Ryoichi Banno et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Discovery of a Potent, Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor for Clinical Study: Identification of (S)-2-(1S,2S,4R)-Bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)
Murielle M. Veniant et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Signal transduction of the CB1 cannabinoid receptor
Gabor Turu et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
Nicholas Michael Morton
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Upcoming market catalysts in Q1 of 2010
Jesse Rosenthal
NATURE REVIEWS DRUG DISCOVERY (2010)
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
Yihai Cao
NATURE REVIEWS DRUG DISCOVERY (2010)
Cellular bioenergetics as a target for obesity therapy
Yu-Hua Tseng et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Pharmacological management of appetite expression in obesity
Jason C. G. Halford et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue
Tracey M. McLaughlin et al.
OBESITY (2010)
Weight Loss, HbA(1c) Reduction, and Tolerability of Cetilistat in a Randomized, Placebo-controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)
Peter Kopelman et al.
OBESITY (2010)
Gastrointestinal targets of appetite regulation in humans
N. Delzenne et al.
OBESITY REVIEWS (2010)
Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity
Franck Thuny et al.
PLOS ONE (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
F. J. Bermudez-Silva et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Endocannabinoids selectively enhance sweet taste
Ryusuke Yoshida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism
Yuguang Shi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Appetite Suppressants, Cardiac Valve Disease and Combination Pharmacotherapy
Richard B. Rothman et al.
AMERICAN JOURNAL OF THERAPEUTICS (2009)
N-acylethanolamines, anandamide and food intake
Harald S. Hansen et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators
Jean E. Bemis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy
R. Krishna et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
CNS-targets in control of energy and glucose homeostasis
Andre Kleinridders et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Promising Strategies for Obesity Pharmacotherapy: Melanocortin-4 (MC-4) Receptor Agonists and Melanin Concentrating Hormone (MCH) Receptor-1 Antagonists
Moon-Kook Jeon et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
Lina M. Lauffer et al.
DIABETES (2009)
Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug
Iskandar Idris et al.
DIABETES OBESITY & METABOLISM (2009)
The histamine H3 receptor as a therapeutic drug target for CNS disorders
Mark J. Gemkow et al.
DRUG DISCOVERY TODAY (2009)
TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders
Atul Tiwari et al.
DRUG DISCOVERY TODAY (2009)
Gut Peptides: Targets for Antiobesity Drug Development?
Timothy H. Moran et al.
ENDOCRINOLOGY (2009)
Molecular Targets for Obesity Therapy in the Brain
Silvana Obici
ENDOCRINOLOGY (2009)
Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes
R. L. Young et al.
GUT (2009)
Acting in good taste: nutrient sensors in the gut
Kelley S. Yan et al.
GUT (2009)
Aerobic Exercise Training Reduces Hepatic and Visceral Lipids in Obese Individuals Without Weight Loss
Nathan A. Johnson et al.
HEPATOLOGY (2009)
Fat distribution in men of different waist girth, fitness level and exercise habit
G. O'Donovan et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis
Hong Lan et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
Roberto Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
On the Central Mechanism Underlying Ghrelin's Chronic Pro-Obesity Effects in Rats: New Insights from Studies Exploiting a Potent Ghrelin Receptor Antagonist
N. Salome et al.
JOURNAL OF NEUROENDOCRINOLOGY (2009)
Pharmacological targeting of the serotonergic system for the treatment of obesity
Alastair S. Garfield et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Arne Astrup et al.
LANCET (2009)
Fanning the flames of obesity-induced inflammation
Steven E. Shoelson et al.
NATURE MEDICINE (2009)
CB1 antagonists for obesity-what lessons have we learned from rimonabant?
Vincenzo Di Marzo et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
The future of obesity reduction: beyond weight loss
Robert Ross et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Brief Report: Functional Brown Adipose Tissue in Healthy Adults.
Kirsi A. Virtanen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cold-Activated Brown Adipose Tissue in Healthy Men
Wouter D. van Marken Lichtenbelt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification and Importance of Brown Adipose Tissue in Adult Humans.
Aaron M. Cypess et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Eric Ravussin et al.
OBESITY (2009)
Lorcaserin (APD356), a Selective 5-HT2C Agonist, Reduces Body Weight in Obese Men and Women
Steven R. Smith et al.
OBESITY (2009)
Gut hormones: Implications for the treatment of obesity
Marianne T. Neary et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
K. S. Sink et al.
PSYCHOPHARMACOLOGY (2009)
BAT: a new target for human obesity?
Gema Fruehbeck et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases
Thekkethil P. Nedungadi et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2009)
Sirtuins: Novel targets for metabolic disease in drug development
Wei-jian Jiang
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity
H. A. Overton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
AMPK and PPARδ Agonists are exercise mimetics
Vihang A. Narkar et al.
CELL (2008)
A Gut Feeling for Obesity: 7TM Sensors on Enteroendocrine Cells
Maja S. Engelstoft et al.
CELL METABOLISM (2008)
Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-induced Metabolic Disorders by Enhancing Fat Oxidation
Jerome N. Feige et al.
CELL METABOLISM (2008)
New approaches to target microsomal triglyceride transfer protein
Mohammed Mahmood Hussain et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
From a glucocentric to a lipocentric approach towards metabolic syndrome
Shivani Mittra et al.
DRUG DISCOVERY TODAY (2008)
Recent advances in the discovery and development of PTP-1B inhibitors
Steve Tam et al.
DRUGS OF THE FUTURE (2008)
Surgical treatment of obesity
Marielle J. F. Bult et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor
Richard Z. Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial
N. Barak et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Update on obesity
Daniel H. Bessesen
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The epidemiology of obesity: the size of the problem
W. P. T. James
JOURNAL OF INTERNAL MEDICINE (2008)
Blockade of glucocorticoid excess at the tissue level:: Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes
Christopher Fotsch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119
Graeme Semple et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity
D. Cota
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity:: Effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats
F. J. Pavon et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141
Galina Bryzgalova et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
Arne Astrup et al.
LANCET (2008)
End of the line for cannabinoid receptor 1 as an anti-obesity target?
Dan Jones
NATURE REVIEWS DRUG DISCOVERY (2008)
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
Adilson Guilherme et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology:: perspectives from β3-adrenoceptor agonists
Jonathan R. S. Arch
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
The exercise pill - Too good to be true?
Laurie J. Goodyear
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic
Youfa Wang et al.
OBESITY (2008)
Selective 5-HT6 receptor ligands:: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders
D. J. Heal et al.
PHARMACOLOGY & THERAPEUTICS (2008)
The effects of two highly selective dopamine D(3) receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity
Panayotis K. Thanos et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides
Jing Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bypassing medicine to treat diabetes
Jennifer Couzin
SCIENCE (2008)
Anti-obesity drugs and neural circuits of feeding
Roger A. H. Adan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients
J. Jordan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Amy Fleischman et al.
DIABETES CARE (2008)
Nutrient sensing and inflammation in metabolic diseases
Goekhan S. Hotamisligil et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Jill C. Milne et al.
NATURE (2007)
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure.: 2.: Synthesis and pharmacological in vitro and in vivo evaluations
Aline Moulin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Relationship between stress, eating behavior, and obesity
Susan J. Torres et al.
NUTRITION (2007)
MCH-R1 antagonists:: what is keeping most research programs away from the clinic?
Jose L. Mendez-Andino et al.
DRUG DISCOVERY TODAY (2007)
Pancreatic lipase inhibitors from natural sources: unexplored potential
Rahul B. Birari et al.
DRUG DISCOVERY TODAY (2007)
Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs
J. A. Vizcarra et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2007)
Abdominal visceral and subcutaneous adipose tissue compartments - Association with metabolic risk factors in the Framingham Heart Study
Caroline S. Fox et al.
CIRCULATION (2007)
Inhibition of 11B-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Malgorzata Wamil et al.
DRUG DISCOVERY TODAY (2007)
No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet
A. Due et al.
DIABETES OBESITY & METABOLISM (2007)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats
Cassio M. Villicev et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Lack of an effect of a novel β3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals:: A double-blind, placebo-controlled randomized study
Leanne M. Redman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Gastrointestinal regulation of food intake
David E. Cummings et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Angiogenesis modulates adipogenesis and obesity
Yihai Cao
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction
Yingkui Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system
P. V. Piazza et al.
DIABETES & METABOLISM (2007)
Microbial ecology - Human gut microbes associated with obesity
Ruth E. Ley et al.
NATURE (2006)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Abdominal obesity and metabolic syndrome
Jean-Pierre Despres et al.
NATURE (2006)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
The MC4 receptor and control of appetite
R. A. H. Adan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Central nervous system control of food intake and body weight
G. J. Morton et al.
NATURE (2006)
Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus
Ryo Yoshimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The obesity epidemic and its cardiovascular consequences
Agnieszka Behn et al.
CURRENT OPINION IN CARDIOLOGY (2006)
Eating for pleasure or just wanting to eat? Reconsidering sensory hedonic responses as a driver of obesity
David J. Mela
APPETITE (2006)
Histamine H3 receptor antagonists:: Preclinical promise for treating obesity and cognitive disorders
TA Esbenshade et al.
MOLECULAR INTERVENTIONS (2006)
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
HA Overton et al.
CELL METABOLISM (2006)
Visceral fat is an independent predictor of all-cause mortality in men
Jennifer L. Kuk et al.
OBESITY (2006)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Cannabinoids, opioids and eating behavior: The molecular face of hedonism?
Daniela Cota et al.
BRAIN RESEARCH REVIEWS (2006)
PYY3-36 as an anti-obesity drug target
MM Boggiano et al.
OBESITY REVIEWS (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
The adipocyte as a drug discovery target
AR Nawrocki et al.
DRUG DISCOVERY TODAY (2005)
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes
I Chapman et al.
DIABETOLOGIA (2005)
Inhibition of triglyceride synthesis as a treatment strategy for obesity - Lessons from DGAT1-deficient mice
HC Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer
S Helmling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Reversal of obesity by targeted ablation of adipose tissue
MG Kolonin et al.
NATURE MEDICINE (2004)
Exercise in a Pill: Feasibility of Energy Expenditure Targets
J. Himms-Hagen
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)
Inhibition of food intake in obese subjects by peptide YY3-36
RL Batterham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia
SP Vickers et al.
PSYCHOPHARMACOLOGY (2003)
Zonisamide for weight loss in obese adults - A randomized controlled trial
KM Gadde et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Adipose tissue mass can be regulated through the vasculature
MA Rupnick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors
SP Vickers et al.
NEUROPHARMACOLOGY (2001)
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
DE Cummings et al.
DIABETES (2001)
Share Paper
